Conmed (CNMD) Long-Term Deferred Tax (2010 - 2025)

Conmed's Long-Term Deferred Tax history runs 16 years deep, the most recent figure standing at $13.3 million for Q4 2025.

• Quarterly Long-Term Deferred Tax rose 20.24% year-over-year to $13.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.3 million (up 20.24% YoY) and the FY2025 annual result came in at $13.3 million, up 20.24% from the prior year.
• Long-Term Deferred Tax was $13.3 million for Q4 2025 at Conmed, up from $11.1 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $13.3 million in Q4 2025 and bottomed at $9.6 million in Q4 2022.
• A 5-year average of $11.0 million and a median of $11.1 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2021 — Long-Term Deferred Tax surged 41.14% — and 2024, when it dropped 1.27%.
• Conmed's Long-Term Deferred Tax stood at $9.7 million in 2021, then decreased by 0.07% to $9.6 million in 2022, then advanced by 16.18% to $11.2 million in 2023, then retreated by 1.27% to $11.1 million in 2024, then advanced by 20.24% to $13.3 million in 2025.
• Business Quant data shows CNMD's Long-Term Deferred Tax at $13.3 million in Q4 2025, $11.1 million in Q4 2024, and $11.2 million in Q4 2023.